Journal article · 2019
Model‐Informed Drug Development: A Regulatory Perspective on Progress
Clinical Pharmacology & Therapeutics, 106(1), 91–93 · Published 4 June 2019 · DOI 10.1002/cpt.1475
In brief
“Model‐Informed Drug Development: A Regulatory Perspective on Progress” is a 2019 journal article by Hao Zhu and 5 co-authors, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 33 citations as of 21 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 33
- Most cited in
- 2023 (6)
- Field-weighted impact
- 3.15
- References
- 4
- Authors
- 6
Abstract
The authors declared no competing interests for this work. As an Associate Editor for Clinical Pharmacology & Therapeutics, S.-M.H. was not involved in the review or decision process for this paper. Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Zhu, H., Huang, S. M., Madabushi, R., Strauss, D. G., Wang, Y., & Zineh, I. (2019). Model‐Informed Drug Development: A Regulatory Perspective on Progress. Clinical Pharmacology & Therapeutics, 106(1), 91–93. https://doi.org/10.1002/cpt.1475
MLA 9
Zhu, Hao, et al. “Model‐Informed Drug Development: A Regulatory Perspective on Progress.” Clinical Pharmacology & Therapeutics, vol. 106, no. 1, 2019, pp. 91–93. https://doi.org/10.1002/cpt.1475.
Chicago
Zhu, Hao, Shiew Mei Huang, Rajanikanth Madabushi, David G. Strauss, Yaning Wang, and Issam Zineh. 2019. “Model‐Informed Drug Development: A Regulatory Perspective on Progress.” Clinical Pharmacology & Therapeutics 106 (1): 91–93. https://doi.org/10.1002/cpt.1475.
Harvard
Zhu, H. et al. (2019) ‘Model‐Informed Drug Development: A Regulatory Perspective on Progress’, Clinical Pharmacology & Therapeutics, 106(1), pp. 91–93. doi:10.1002/cpt.1475.
IEEE
H. Zhu, S. M. Huang, R. Madabushi, D. G. Strauss, Y. Wang, and I. Zineh, “Model‐Informed Drug Development: A Regulatory Perspective on Progress,” Clinical Pharmacology & Therapeutics, vol. 106, no. 1, pp. 91–93, 2019, doi: 10.1002/cpt.1475.
BibTeX
@article{zhu2019model,
title = {{Model‐Informed Drug Development: A Regulatory Perspective on Progress}},
author = {Zhu, Hao and Huang, Shiew Mei and Madabushi, Rajanikanth and Strauss, David G. and Wang, Yaning and Zineh, Issam},
journal = {Clinical Pharmacology \& Therapeutics},
year = {2019},
volume = {106},
number = {1},
pages = {91--93},
doi = {10.1002/cpt.1475},
url = {https://doi.org/10.1002/cpt.1475}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2019 | 2 | |
| 2020 | 3 | |
| 2021 | 5 | |
| 2022 | 4 | |
| 2023 | 6 | |
| 2024 | 6 | |
| 2025 | 1 | |
| 2026 | 6 |
Its field-weighted citation impact is 3.15: it has been cited 3.15 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- model-informed drug development
- regulatory science
- regulatory perspectives
- drug development
- clinical pharmacology
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Zhu, H., Huang, S. M., Madabushi, R., Strauss, D. G., Wang, Y., & Zineh, I. (2019). Model‐Informed Drug Development: A Regulatory Perspective on Progress. Clinical Pharmacology & Therapeutics, 106(1), 91–93. https://doi.org/10.1002/cpt.1475
How many times has this paper been cited?
33 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Hao Zhu, Shiew Mei Huang, Rajanikanth Madabushi, David G. Strauss, Yaning Wang, Issam Zineh.
What is the DOI of this paper?
10.1002/cpt.1475, permanently at https://doi.org/10.1002/cpt.1475. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.